PT-2019-7185 · Hospira · Hospira Symbiq Infusion System

Billy Rios · Publicado 2019-03-23 · Atualizado 2019-03-25 · CVE-2015-3965

Positive Technologies (AI Summary)

CVSS v2.0

9.0

Alta

Vetor base

AV:N/AC:L/Au:S/C:C/I:C/A:C

Name of the Vulnerable Software and Affected Versions Hospira Symbiq Infusion System versions 3.13 and earlier

Description The issue allows remote authenticated users to trigger unanticipated operations by leveraging elevated privileges for an unspecified call to an incorrectly exposed function.

Recommendations For Hospira Symbiq Infusion System versions 3.13 and earlier, at the moment, there is no information about a newer version that contains a fix for this vulnerability.

Enumeração de Fraquezas

CWE-264

Identificadores relacionados

CVE-2015-3965

Produtos afetados

Hospira Symbiq Infusion System

Referências · 2

• https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01 · Nota
• https://nvd.nist.gov/vuln/detail/CVE-2015-3965 · Nota de Segurança